NL-OMON47319尚未招募不适用
ung cancer Early Molecular Assessment trial - Lung cancer Early Molecular Assessment trial:LEMA
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 1,297 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,297
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Suspicion of lung carcinoma or established NSCLC but awaiting start of definitive treatment
- •- Written informed consent to undergo diagnostic procedure and molecular analysis of the disease.
排除标准
- •- Not motivated to receive any treatment at any point in time. Patients who consider undergoing treatment in the future are eligible.
研究者
相似试验
招募中
不适用
'A one-day diagnostic track for lung cancer suspects from chest X-ray using PET-CT and subsequent multiple endoscopic investigations. (including bronchoscopy, EUS-FNA and EBUS-TBNA)'.NL-OMON29952Isala Klinieken100
招募中
Unknown
ung Cancer Genomic Screening Project for Neoadjuvant and Adjuvant setting Molecular Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer and the Assessment of monitoring Minimal Residual Diseaseung cancerJPRN-UMIN000048977ational Cancer Center10,680
进行中（未招募）
1 期
A Phase I/II trial of UCB4594 in participants with advanced cancerAdvanced solid tumoursCancerISRCTN26628699Cancer Research UK167
进行中（未招募）
1 期
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3Small Cell Lung Carcinoma (SCLC)Neuroendocrine NeoplasmsNCT05879978Boehringer Ingelheim45
已完成
1 期
A Phase I/IIa trial of BT1718 in patients with advanced solid tumours.CancerISRCTN11160449Cancer Research UK66